TETRATHERIX
LIVE

Serial Number

79394877

Owner

Trimph Pty Limited

Attorney

Jeffrey P. Dunning

Filing Date

Mar 15, 2024

Add to watchlist:

No watchlists yet
View on USPTO

TETRATHERIX Trademark

Serial Number: 79394877 • Registration: 7830550

TETRATHERIX is a trademark filed by Trimph Pty Limited on March 15, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Trimph Pty Limited (2 trademarks)

MLC Centre L53,

Entity Type: 82

Trademark Details

Filing Date

March 15, 2024

Registration Date

June 17, 2025

Published for Opposition

April 29, 2025

Goods & Services

Medical preparations for the repair of damaged tissue and tissue regeneration; chemical preparations for medical purposes, namely, for the repair of damaged tissue and tissue regeneration; chemical preparations for pharmaceutical purposes, namely, for the repair of damaged tissue and tissue regeneration; chemical products for medical use for the repair of damaged tissue and tissue regeneration; chemical reagents for use in medicine; chemical test reagents for medical purposes; chemicals having antimicrobial properties for medical purposes, namely, for the repair of damaged tissue and tissue regeneration; diluents for medical use being fully synthetic biomaterial for use in the repair of damaged tissue and tissue regeneration; injectable solutions for medical purposes, namely, for the repair of damaged tissue and tissue regeneration; polymer coatings for medical use, namely, for the repair of damaged tissue and tissue regeneration; sprays for use on the body being medicaments for use in connection with the repair of damaged tissue and tissue regeneration; sterilising solutions; sterilising preparations; surgical adhesives for the repair of damaged tissue and tissue regeneration; synthetic resins for surgical and medical use, namely, for the repair of damaged tissue and tissue regeneration; anti-viral agents being antivirals; biochemical preparations for medical use, namely, for the repair of damaged tissue and tissue regeneration; bone cement for surgical and orthopaedic use; anaesthetic preparations, namely, anesthetics for surgical and non-surgical use * ; all of the aforementioned being for human and none of the aforementioned being for pets *

Scientific research including in the field of material science; chemical research; medical research; medical research laboratory services; design of medical apparatus

Medical and surgical devices, namely, devices for the repair of damaged tissue and tissue regeneration; medical apparatus and instruments, namely, apparatus and instruments for the repair of damaged tissue and tissue regeneration, and surgical apparatus and instruments; medical grafts, namely, synthetic bone grafts, synthetic stent grafts, artificial vascular grafts; surgical graft material, namely, synthetic media for use in the augmentation of bone and tissue for medical purposes; medical syringes; orthopaedic articles, namely, orthopaedic implants made of artificial materials; evaporators for liquid anaesthetics, namely, anaesthetic inhalers, sold empty; chemical analysers being apparatus for medical use, namely, medical diagnostic instruments for the analysis of body fluids; * computer apparatus for use in * monitoring [ instruments for ] biochemical reactions for medical * use * [ purposes, to be used with computer apparatus, ] namely, medical instruments for monitoring vital signs, blood properties and respiratory events; hand-operated hand sprayers, for medical use, namely, sprayers for application of chemical preparations during medical procedures; power-operated sprayers for medical use, namely, sprayers for application of chemical preparations during medical procedures

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 5, 2026 FINO
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Feb 3, 2026 NURC
FINAL DISPOSITION NOTICE SENT TO IB
Jan 15, 2026 FICS
LIMITATION FROM THE IB EXAMINED AND ENTERED
Jan 15, 2026 LIME
FINAL DISPOSITION PROCESSED
Jan 15, 2026 FIMP
CORRECTION UNDER SECTION 7 - PROCESSED
Jan 14, 2026 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 14, 2026 APRE
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 18, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 2, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 2, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 17, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 17, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 17, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 23, 2025 NONP
LIMITATION OF GOODS RECEIVED FROM IB
Apr 18, 2025 LIMG
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2025 CNSA
ASSIGNED TO EXAMINER
Mar 25, 2025 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 20, 2025 TROA
ASSIGNED TO EXAMINER
Nov 30, 2024 DOCK
REFUSAL PROCESSED BY IB
Oct 26, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 8, 2024 RFCS
REFUSAL PROCESSED BY MPU
Oct 8, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 2, 2024 RFCR
NON-FINAL ACTION WRITTEN
Oct 1, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 25, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
May 14, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 14, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 2, 2024 REPR